<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:dc="http://purl.org/dc/elements/1.1/">
<channel>
<title>心血管高分期刊</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/rss-feed/?feed_id=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;ff=20230930040904&amp;v=2.17.9.post6+86293ac&amp;utm_source=Chrome&amp;utm_medium=rss&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;utm_campaign=pubmed-2
    <description>心血管高分期刊: Latest results from PubMed</description>
<atom:link href="https://pubmed.ncbi.nlm.nih.gov/rss-feed/?feed_id=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;ff=20230930040904&amp;v=2.17.9.post6+86293ac&amp;utm_source=Chrome&amp;utm_medium=rss&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;utm_campaign=pubmed-2" rel="self"></atom:link>
<docs>http://www.rssboard.org/rss-specification</docs>
<generator>PubMed RSS feeds (2.17.9.post6+86293ac)</generator>
<language>en</language>
<lastbuilddate>Sat, 30 Sep 2023 08:09:05 +0000</lastbuilddate>
<pubDate>Fri, 29 Sep 2023 06:00:00 -0400</pubDate>
<ttl>120</ttl>
<item>
<title>An Indian female cardiologist's journey from 'TAWA' to 'TAVI-transcatheter aortic valve implantation'</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37774363/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230930040904&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2023 Sep 29:ehad652. doi: 10.1093/eurheartj/ehad652. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37774363/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230930040904&v=2.17.9.post6+86293ac">37774363</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehad652>10.1093/eurheartj/ehad652</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37774363</guid>
<pubDate>Fri, 29 Sep 2023 06:00:00 -0400</pubDate>
<dc:creator>Shibba Takkar Chhabra</dc:creator>
<dc:creator>Aastha Takkar</dc:creator>
<dc:creator>Rajesh Chand Arya</dc:creator>
<dc:date>2023-09-29</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>An Indian female cardiologist's journey from 'TAWA' to 'TAVI-transcatheter aortic valve implantation'</dc:title>
<dc:identifier>pmid:37774363</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehad652</dc:identifier>
</item>
<item>
<title>Computed Tomography Cardiac Angiography Before Invasive Coronary Angiography in Patients With Previous Bypass Surgery: The BYPASS-CTCA Trial</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37772419/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230930040904&amp;v=2.17.9.post6+86293ac
      <description>CONCLUSIONS: For patients with previous coronary artery bypass grafting, CTCA before ICA leads to reductions in procedure time and contrast-induced nephropathy, with improved patient satisfaction. CTCA before ICA should be considered in this group of patients.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2023 Sep 29. doi: 10.1161/CIRCULATIONAHA.123.064465. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND: Patients with previous coronary artery bypass grafting often require invasive coronary angiography (ICA). However, for these patients, the procedure is technically more challenging and has a higher risk of complications. Observational studies suggest that computed tomography cardiac angiography (CTCA) may facilitate ICA in this group, but this has not been tested in a randomized controlled trial.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: This study was a single-center, open-label randomized controlled trial assessing the benefit of adjunctive CTCA in patients with previous coronary artery bypass grafting referred for ICA. Patients were randomized 1:1 to undergo CTCA before ICA or ICA alone. The co-primary end points were procedural duration of the ICA (defined as the interval between local anesthesia administration for obtaining vascular access and removal of the last catheter), patient satisfaction after ICA using a validated questionnaire, and the incidence of contrast-induced nephropathy. Linear regression was used for procedural duration and patient satisfaction score; contrast-induced nephropathy was analyzed using logistic regression. We applied the Bonferroni correction, with <i>P</i>&lt;0.017 considered significant and 98.33% CIs presented. Secondary end points included incidence of procedural complications and 1-year major adverse cardiac events.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: Over 3 years, 688 patients were randomized with a median follow-up of 1.0 years. The mean age was 69.8±10.4 years, 108 (15.7%) were women, 402 (58.4%) were White, and there was a high burden of comorbidity (85.3% hypertension and 53.8% diabetes). The median time from coronary artery bypass grafting to angiography was 12.0 years, and there were a median of 3 (interquartile range, 2 to 3) grafts per participant. Procedure duration of the ICA was significantly shorter in the CTCA+ICA group (CTCA+ICA, 18.6±9.5 minutes versus ICA alone, 39.5±16.9 minutes [98.33% CI, -23.5 to -18.4]; <i>P</i>&lt;0.001), alongside improved mean ICA satisfaction scores (1=very good to 5=very poor; -1.1 difference [98.33% CI, -1.2 to -0.9]; <i>P</i>&lt;0.001), and reduced incidence of contrast-induced nephropathy (3.4% versus 27.9%; odds ratio, 0.09 [98.33% CI, 0.04-0.2]; <i>P</i>&lt;0.001). Procedural complications (2.3% versus 10.8%; odds ratio, 0.2 [95% CI, 0.1-0.4]; <i>P</i>&lt;0.001) and 1-year major adverse cardiac events (16.0% versus 29.4%; hazard ratio, 0.4 [95% CI, 0.3-0.6]; <i>P</i>&lt;0.001) were also lower in the CTCA+ICA group.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: For patients with previous coronary artery bypass grafting, CTCA before ICA leads to reductions in procedure time and contrast-induced nephropathy, with improved patient satisfaction. CTCA before ICA should be considered in this group of patients.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">REGISTRATION: URL: https://www.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CLINICALTRIALS: gov; Unique identifier: NCT03736018.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37772419/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230930040904&v=2.17.9.post6+86293ac">37772419</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.123.064465>10.1161/CIRCULATIONAHA.123.064465</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37772419</guid>
<pubDate>Fri, 29 Sep 2023 06:00:00 -0400</pubDate>
<dc:creator>Daniel A Jones</dc:creator>
<dc:creator>Anne-Marie Beirne</dc:creator>
<dc:creator>Matthew Kelham</dc:creator>
<dc:creator>Krishnaraj S Rathod</dc:creator>
<dc:creator>Mervyn Andiapen</dc:creator>
<dc:creator>Lucinda Wynne</dc:creator>
<dc:creator>Thomas Godec</dc:creator>
<dc:creator>Nasim Forooghi</dc:creator>
<dc:creator>Rohini Ramaseshan</dc:creator>
<dc:creator>James C Moon</dc:creator>
<dc:creator>Ceri Davies</dc:creator>
<dc:creator>Christos V Bourantas</dc:creator>
<dc:creator>Andreas Baumbach</dc:creator>
<dc:creator>Charlotte Manisty</dc:creator>
<dc:creator>Andrew Wragg</dc:creator>
<dc:creator>Amrita Ahluwalia</dc:creator>
<dc:creator>Francesca Pugliese</dc:creator>
<dc:creator>Anthony Mathur</dc:creator>
<dc:creator>BYPASS-CTCA Trial Committees and Investigators</dc:creator>
<dc:date>2023-09-29</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Computed Tomography Cardiac Angiography Before Invasive Coronary Angiography in Patients With Previous Bypass Surgery: The BYPASS-CTCA Trial</dc:title>
<dc:identifier>pmid:37772419</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.123.064465</dc:identifier>
</item>
<item>
<title>An Anterior Second Heart Field Enhancer Regulates the Gene Regulatory Network of the Cardiac Outflow Tract</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37772400/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230930040904&amp;v=2.17.9.post6+86293ac
      <description>CONCLUSIONS: Our results using human and mouse models reveal an essential gene regulatory network of the OFT that requires an anterior second heart field enhancer to link GATA6 with NKX2-5-dependent rotation and septation gene programs.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2023 Sep 29. doi: 10.1161/CIRCULATIONAHA.123.065700. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND: Conotruncal defects due to developmental abnormalities of the outflow tract (OFT) are an important cause of cyanotic congenital heart disease. Dysregulation of transcriptional programs tuned by NKX2-5, GATA6, and TBX1 have been implicated in abnormal OFT morphogenesis. However, there remains no consensus on how these transcriptional programs function in a unified gene regulatory network within the OFT.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: We generated mice harboring a 226-nucleotide deletion of a highly conserved cardiac enhancer containing 2 GATA-binding sites located ≈9.4 kb upstream of the transcriptional start site of <i>Nkx2-5</i> (<i>Nkx2-5</i><sup><i>∆enh</i></sup>) using CRISPR-Cas9 gene editing and assessed phenotypes. Cardiac defects in <i>Nkx2-5</i><sup><i>∆enh/∆enh</i></sup> mice were structurally characterized using histology and scanning electron micrography, and physiologically assessed using electrocardiography, echocardiography, and optical mapping. Transcriptome analyses were performed using RNA sequencing and single-cell RNA sequencing data sets. Endogenous GATA6 interaction with and activity on the <i>NKX2-5</i> enhancer was studied using chromatin immunoprecipitation sequencing and transposase-accessible chromatin sequencing in human induced pluripotent stem cell-derived cardiomyocytes.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: <i>Nkx2-5</i><sup><i>∆enh/∆enh</i></sup> mice recapitulated cyanotic conotruncal defects seen in patients with <i>NKX2-5, GATA6,</i> and <i>TBX1</i> mutations. <i>Nkx2-5</i><sup><i>∆enh/∆enh</i></sup> mice also exhibited defects in right Purkinje fiber network formation, resulting in right bundle-branch block. Enhancer deletion reduced embryonic <i>Nkx2-5</i> expression selectively in the right ventricle and OFT of mutant hearts, indicating that enhancer activity is localized to the anterior second heart field. Transcriptional profiling of the mutant OFT revealed downregulation of important genes involved in OFT rotation and septation, such as <i>Tbx1, Pitx2,</i> and <i>Sema3c</i>. Endogenous GATA6 interacted with the highly conserved enhancer in human induced pluripotent stem cell-derived cardiomyocytes and in wild-type mouse hearts. We found critical dose dependency of cardiac enhancer accessibility on GATA6 gene dosage in human induced pluripotent stem cell-derived cardiomyocytes.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: Our results using human and mouse models reveal an essential gene regulatory network of the OFT that requires an anterior second heart field enhancer to link GATA6 with NKX2-5-dependent rotation and septation gene programs.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37772400/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230930040904&v=2.17.9.post6+86293ac">37772400</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.123.065700>10.1161/CIRCULATIONAHA.123.065700</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37772400</guid>
<pubDate>Fri, 29 Sep 2023 06:00:00 -0400</pubDate>
<dc:creator>Naoko Yamaguchi</dc:creator>
<dc:creator>Ernest W Chang</dc:creator>
<dc:creator>Ziyan Lin</dc:creator>
<dc:creator>Akshay Shekhar</dc:creator>
<dc:creator>Lei Bu</dc:creator>
<dc:creator>Alireza Khodadadi-Jamayran</dc:creator>
<dc:creator>Aristotelis Tsirigos</dc:creator>
<dc:creator>Yiyun Cen</dc:creator>
<dc:creator>Colin K L Phoon</dc:creator>
<dc:creator>Ivan P Moskowitz</dc:creator>
<dc:creator>David S Park</dc:creator>
<dc:date>2023-09-29</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>An Anterior Second Heart Field Enhancer Regulates the Gene Regulatory Network of the Cardiac Outflow Tract</dc:title>
<dc:identifier>pmid:37772400</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.123.065700</dc:identifier>
</item>
<item>
<title>The ESC Working Group on Coronary Pathophysiology and Microcirculation</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37772387/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230930040904&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2023 Sep 29:ehad650. doi: 10.1093/eurheartj/ehad650. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37772387/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230930040904&v=2.17.9.post6+86293ac">37772387</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehad650>10.1093/eurheartj/ehad650</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37772387</guid>
<pubDate>Fri, 29 Sep 2023 06:00:00 -0400</pubDate>
<dc:creator>Teresa Padro</dc:creator>
<dc:creator>Edina Cenko</dc:creator>
<dc:creator>Dimitris Tousoulis</dc:creator>
<dc:date>2023-09-29</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>The ESC Working Group on Coronary Pathophysiology and Microcirculation</dc:title>
<dc:identifier>pmid:37772387</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehad650</dc:identifier>
</item>
<item>
<title>Preclinicaltrials.eu: prospective registration of animal studies</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37769667/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230930040904&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2023 Sep 28:ehad623. doi: 10.1093/eurheartj/ehad623. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37769667/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230930040904&v=2.17.9.post6+86293ac">37769667</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehad623>10.1093/eurheartj/ehad623</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37769667</guid>
<pubDate>Thu, 28 Sep 2023 06:00:00 -0400</pubDate>
<dc:creator>Julia M L Menon</dc:creator>
<dc:creator>Mira van der Naald</dc:creator>
<dc:creator>Steven A J Chamuleau</dc:creator>
<dc:creator>Dirk J Duncker</dc:creator>
<dc:date>2023-09-28</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Preclinicaltrials.eu: prospective registration of animal studies</dc:title>
<dc:identifier>pmid:37769667</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehad623</dc:identifier>
</item>
<item>
<title>Systemic immune profiling of Omicron-infected subjects inoculated with different doses of inactivated virus vaccine</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37769658/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230930040904&amp;v=2.17.9.post6+86293ac
      <description>SARS-CoV-2 primary strain-based vaccination exerts a protective effect against Omicron variants-initiated infection, symptom occurrence, and disease severity in a booster-dependent manner. Yet, the underlying mechanisms remain unclear. During the 2022 Omicron outbreak in Shanghai, we enrolled 122 infected adults and 50 uninfected controls who had been unvaccinated or vaccinated with two or three doses of COVID-19 inactive vaccines and performed integrative analysis of 41-plex CyTOF, RNA-seq, and...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2023 Sep 20:S0092-8674(23)00964-9. doi: 10.1016/j.cell.2023.08.033. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">SARS-CoV-2 primary strain-based vaccination exerts a protective effect against Omicron variants-initiated infection, symptom occurrence, and disease severity in a booster-dependent manner. Yet, the underlying mechanisms remain unclear. During the 2022 Omicron outbreak in Shanghai, we enrolled 122 infected adults and 50 uninfected controls who had been unvaccinated or vaccinated with two or three doses of COVID-19 inactive vaccines and performed integrative analysis of 41-plex CyTOF, RNA-seq, and Olink on their peripheral blood samples. The frequencies of HLA-DR<sup>hi</sup> classical monocytes, non-classical monocytes, and Th1-like Tem tended to increase, whereas the frequency of Treg was reduced by booster vaccine, and they influenced symptom occurrence in a vaccine dose-dependent manner. Intercorrelation and mechanistic analysis suggested that the booster vaccination induced monocytic training, which would prime monocytic activation and maturation rather than differentiating into myeloid-derived suppressive cells upon Omicron infections. Overall, our study provides insights into how booster vaccination elaborates protective immunity across SARS-CoV-2 variants.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37769658/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230930040904&v=2.17.9.post6+86293ac">37769658</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2023.08.033>10.1016/j.cell.2023.08.033</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37769658</guid>
<pubDate>Thu, 28 Sep 2023 06:00:00 -0400</pubDate>
<dc:creator>Shanhe Yu</dc:creator>
<dc:creator>Yingni Lin</dc:creator>
<dc:creator>Yong Li</dc:creator>
<dc:creator>Shijun Chen</dc:creator>
<dc:creator>Lina Zhou</dc:creator>
<dc:creator>Hejie Song</dc:creator>
<dc:creator>Cuiping Yang</dc:creator>
<dc:creator>Haiqing Zhang</dc:creator>
<dc:creator>Jianping Zhou</dc:creator>
<dc:creator>Shunchang Sun</dc:creator>
<dc:creator>Yanan Li</dc:creator>
<dc:creator>Juan Chen</dc:creator>
<dc:creator>Ruixue Feng</dc:creator>
<dc:creator>Niu Qiao</dc:creator>
<dc:creator>Yinyin Xie</dc:creator>
<dc:creator>Ruihong Zhang</dc:creator>
<dc:creator>Tong Yin</dc:creator>
<dc:creator>Saijuan Chen</dc:creator>
<dc:creator>Qingyun Li</dc:creator>
<dc:creator>Jiang Zhu</dc:creator>
<dc:creator>Jieming Qu</dc:creator>
<dc:date>2023-09-28</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Systemic immune profiling of Omicron-infected subjects inoculated with different doses of inactivated virus vaccine</dc:title>
<dc:identifier>pmid:37769658</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2023.08.033</dc:identifier>
</item>
<item>
<title>The local microenvironment drives activation of neutrophils in human brain tumors</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37769657/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230930040904&amp;v=2.17.9.post6+86293ac
      <description>Neutrophils are abundant immune cells in the circulation and frequently infiltrate tumors in substantial numbers. However, their precise functions in different cancer types remain incompletely understood, including in the brain microenvironment. We therefore investigated neutrophils in tumor tissue of glioma and brain metastasis patients, with matched peripheral blood, and herein describe the first in-depth analysis of neutrophil phenotypes and functions in these tissues. Orthogonal profiling...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2023 Sep 23:S0092-8674(23)00977-7. doi: 10.1016/j.cell.2023.08.043. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Neutrophils are abundant immune cells in the circulation and frequently infiltrate tumors in substantial numbers. However, their precise functions in different cancer types remain incompletely understood, including in the brain microenvironment. We therefore investigated neutrophils in tumor tissue of glioma and brain metastasis patients, with matched peripheral blood, and herein describe the first in-depth analysis of neutrophil phenotypes and functions in these tissues. Orthogonal profiling strategies in humans and mice revealed that brain tumor-associated neutrophils (TANs) differ significantly from blood neutrophils and have a prolonged lifespan and immune-suppressive and pro-angiogenic capacity. TANs exhibit a distinct inflammatory signature, driven by a combination of soluble inflammatory mediators including tumor necrosis factor alpha (TNF-ɑ) and Ceruloplasmin, which is more pronounced in TANs from brain metastasis versus glioma. Myeloid cells, including tumor-associated macrophages, emerge at the core of this network of pro-inflammatory mediators, supporting the concept of a critical myeloid niche regulating overall immune suppression in human brain tumors.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37769657/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230930040904&v=2.17.9.post6+86293ac">37769657</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2023.08.043>10.1016/j.cell.2023.08.043</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37769657</guid>
<pubDate>Thu, 28 Sep 2023 06:00:00 -0400</pubDate>
<dc:creator>Roeltje R Maas</dc:creator>
<dc:creator>Klara Soukup</dc:creator>
<dc:creator>Nadine Fournier</dc:creator>
<dc:creator>Matteo Massara</dc:creator>
<dc:creator>Sabine Galland</dc:creator>
<dc:creator>Mara Kornete</dc:creator>
<dc:creator>Vladimir Wischnewski</dc:creator>
<dc:creator>Joao Lourenco</dc:creator>
<dc:creator>Davide Croci</dc:creator>
<dc:creator>Ángel F Álvarez-Prado</dc:creator>
<dc:creator>Damien N Marie</dc:creator>
<dc:creator>Johanna Lilja</dc:creator>
<dc:creator>Rachel Marcone</dc:creator>
<dc:creator>Gabriel F Calvo</dc:creator>
<dc:creator>Rui Santalla Mendez</dc:creator>
<dc:creator>Pauline Aubel</dc:creator>
<dc:creator>Leire Bejarano</dc:creator>
<dc:creator>Pratyaksha Wirapati</dc:creator>
<dc:creator>Iván Ballesteros</dc:creator>
<dc:creator>Andrés Hidalgo</dc:creator>
<dc:creator>Andreas F Hottinger</dc:creator>
<dc:creator>Jean-Philippe Brouland</dc:creator>
<dc:creator>Roy T Daniel</dc:creator>
<dc:creator>Monika E Hegi</dc:creator>
<dc:creator>Johanna A Joyce</dc:creator>
<dc:date>2023-09-28</dc:date>
<dc:source>Cell</dc:source>
<dc:title>The local microenvironment drives activation of neutrophils in human brain tumors</dc:title>
<dc:identifier>pmid:37769657</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2023.08.043</dc:identifier>
</item>
<item>
<title>Light the FIRE of revascularization in older patients with myocardial infarction</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37769442/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230930040904&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2023 Sep 28:ehad638. doi: 10.1093/eurheartj/ehad638. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37769442/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230930040904&v=2.17.9.post6+86293ac">37769442</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehad638>10.1093/eurheartj/ehad638</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37769442</guid>
<pubDate>Thu, 28 Sep 2023 06:00:00 -0400</pubDate>
<dc:creator>Rocco Vergallo</dc:creator>
<dc:creator>Massimo Volpe</dc:creator>
<dc:date>2023-09-28</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Light the FIRE of revascularization in older patients with myocardial infarction</dc:title>
<dc:identifier>pmid:37769442</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehad638</dc:identifier>
</item>
<item>
<title>Low carbohydrate/ketogenic diet in the optimization of lipoprotein(a) levels: do we have sufficient evidence for any recommendation?</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37769437/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230930040904&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2023 Sep 28:ehad635. doi: 10.1093/eurheartj/ehad635. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37769437/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230930040904&v=2.17.9.post6+86293ac">37769437</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehad635>10.1093/eurheartj/ehad635</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37769437</guid>
<pubDate>Thu, 28 Sep 2023 06:00:00 -0400</pubDate>
<dc:creator>Stanisław Surma</dc:creator>
<dc:creator>Amirhossein Sahebkar</dc:creator>
<dc:creator>Maciej Banach</dc:creator>
<dc:creator>endorsed by the International Lipid Expert Panel (ILEP)</dc:creator>
<dc:date>2023-09-28</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Low carbohydrate/ketogenic diet in the optimization of lipoprotein(a) levels: do we have sufficient evidence for any recommendation?</dc:title>
<dc:identifier>pmid:37769437</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehad635</dc:identifier>
</item>
<item>
<title>Complex mitral para-prosthetic leak closure as a bridge to heart transplant</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37769354/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230930040904&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2023 Sep 28:ehad602. doi: 10.1093/eurheartj/ehad602. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37769354/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230930040904&v=2.17.9.post6+86293ac">37769354</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehad602>10.1093/eurheartj/ehad602</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37769354</guid>
<pubDate>Thu, 28 Sep 2023 06:00:00 -0400</pubDate>
<dc:creator>Farzin Beygui</dc:creator>
<dc:creator>Valentin Guillemot</dc:creator>
<dc:creator>Eric Saloux</dc:creator>
<dc:date>2023-09-28</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Complex mitral para-prosthetic leak closure as a bridge to heart transplant</dc:title>
<dc:identifier>pmid:37769354</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehad602</dc:identifier>
</item>
<item>
<title>Percutaneous closure of infantile postoperative left ventricular pseudoaneurysm exclusively under transthoracic echocardiography guidance</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37769353/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230930040904&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2023 Sep 28:ehad606. doi: 10.1093/eurheartj/ehad606. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37769353/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230930040904&v=2.17.9.post6+86293ac">37769353</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehad606>10.1093/eurheartj/ehad606</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37769353</guid>
<pubDate>Thu, 28 Sep 2023 06:00:00 -0400</pubDate>
<dc:creator>Huai-Xue Mi</dc:creator>
<dc:creator>Peng-Peng Wu</dc:creator>
<dc:creator>Li Hongxin</dc:creator>
<dc:date>2023-09-28</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Percutaneous closure of infantile postoperative left ventricular pseudoaneurysm exclusively under transthoracic echocardiography guidance</dc:title>
<dc:identifier>pmid:37769353</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehad606</dc:identifier>
</item>
<item>
<title>The Vienna Prediction Model for identifying patients at low risk of recurrent venous thromboembolism: a prospective cohort study</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37769352/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230930040904&amp;v=2.17.9.post6+86293ac
      <description>CONCLUSIONS: In this prospective evaluation of the performance of the VPM, the 1-year rate of recurrence in patients with unprovoked VTE was 5.2%. Recalibration improved identification of patients at low recurrence risk and stratification into distinct low-risk categories.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2023 Sep 28:ehad618. doi: 10.1093/eurheartj/ehad618. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND AND AIMS: Patients with unprovoked venous thromboembolism (VTE) have a high recurrence risk, and guidelines suggest extended-phase anticoagulation. Many patients never experience recurrence but are exposed to bleeding. The aim of this study was to assess the performance of the Vienna Prediction Model (VPM) and to evaluate if the VPM accurately identifies these patients.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: In patients with unprovoked VTE, the VPM was performed 3 weeks after anticoagulation withdrawal. Those with a predicted 1-year recurrence risk of ≤5.5% were prospectively followed. Study endpoint was recurrent VTE over 2 years.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: A total of 818 patients received anticoagulation for a median of 3.9 months. 520 patients (65%) had a predicted annual recurrence risk of ≤5.5%. During a median time of 23.9 months, 52 patients had non-fatal recurrence. The recurrence risk was 5.2% [95% confidence interval (CI) 3.2-7.2] at 1 year and 11.2% (95% CI 8.3-14) at 2 years. Model calibration was adequate after 1 year. The VPM underestimated the recurrence risk of patients with a 2-year recurrence rate of >;5%. In a post-hoc analysis, the VPM's baseline hazard was recalibrated. Bootstrap validation confirmed an ideal ratio of observed and expected recurrence events. The recurrence risk was highest in men with proximal deep-vein thrombosis or pulmonary embolism and lower in women regardless of the site of incident VTE.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: In this prospective evaluation of the performance of the VPM, the 1-year rate of recurrence in patients with unprovoked VTE was 5.2%. Recalibration improved identification of patients at low recurrence risk and stratification into distinct low-risk categories.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37769352/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230930040904&v=2.17.9.post6+86293ac">37769352</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehad618>10.1093/eurheartj/ehad618</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37769352</guid>
<pubDate>Thu, 28 Sep 2023 06:00:00 -0400</pubDate>
<dc:creator>Paul A Kyrle</dc:creator>
<dc:creator>Lisbeth Eischer</dc:creator>
<dc:creator>Hana Šinkovec</dc:creator>
<dc:creator>Paul Gressenberger</dc:creator>
<dc:creator>Thomas Gary</dc:creator>
<dc:creator>Marianne Brodmann</dc:creator>
<dc:creator>Georg Heinze</dc:creator>
<dc:creator>Sabine Eichinger</dc:creator>
<dc:date>2023-09-28</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>The Vienna Prediction Model for identifying patients at low risk of recurrent venous thromboembolism: a prospective cohort study</dc:title>
<dc:identifier>pmid:37769352</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehad618</dc:identifier>
</item>
<item>
<title>Constrictive pericarditis: mitral inflow and septal shudder as diagnostic red flags and evolution of echocardiographic and clinical data after treatment</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37769349/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230930040904&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2023 Sep 28:ehad633. doi: 10.1093/eurheartj/ehad633. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37769349/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230930040904&v=2.17.9.post6+86293ac">37769349</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehad633>10.1093/eurheartj/ehad633</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37769349</guid>
<pubDate>Thu, 28 Sep 2023 06:00:00 -0400</pubDate>
<dc:creator>Iwona Duraj</dc:creator>
<dc:creator>Daniel Steter</dc:creator>
<dc:creator>Karina Wierzbowska-Drabik</dc:creator>
<dc:date>2023-09-28</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Constrictive pericarditis: mitral inflow and septal shudder as diagnostic red flags and evolution of echocardiographic and clinical data after treatment</dc:title>
<dc:identifier>pmid:37769349</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehad633</dc:identifier>
</item>
<item>
<title>Aortic intimal intussusception induced by stent-graft during endovascular repair of acute type B aortic dissection</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37769348/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230930040904&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2023 Sep 28:ehad604. doi: 10.1093/eurheartj/ehad604. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37769348/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230930040904&v=2.17.9.post6+86293ac">37769348</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehad604>10.1093/eurheartj/ehad604</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37769348</guid>
<pubDate>Thu, 28 Sep 2023 06:00:00 -0400</pubDate>
<dc:creator>Jiehua Li</dc:creator>
<dc:creator>Quanming Li</dc:creator>
<dc:creator>Chang Shu</dc:creator>
<dc:date>2023-09-28</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Aortic intimal intussusception induced by stent-graft during endovascular repair of acute type B aortic dissection</dc:title>
<dc:identifier>pmid:37769348</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehad604</dc:identifier>
</item>
<item>
<title>Higher cardiovascular risk for women throughout the glycaemic spectrum: only a question of sex?</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37769346/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230930040904&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2023 Sep 28:ehad612. doi: 10.1093/eurheartj/ehad612. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37769346/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230930040904&v=2.17.9.post6+86293ac">37769346</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehad612>10.1093/eurheartj/ehad612</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37769346</guid>
<pubDate>Thu, 28 Sep 2023 06:00:00 -0400</pubDate>
<dc:creator>Daniela Pedicino</dc:creator>
<dc:creator>Leonarda Galiuto</dc:creator>
<dc:date>2023-09-28</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Higher cardiovascular risk for women throughout the glycaemic spectrum: only a question of sex?</dc:title>
<dc:identifier>pmid:37769346</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehad612</dc:identifier>
</item>
<item>
<title>Cardiac tamponade related oesophageal perforation</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37769345/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230930040904&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2023 Sep 28:ehad600. doi: 10.1093/eurheartj/ehad600. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37769345/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230930040904&v=2.17.9.post6+86293ac">37769345</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehad600>10.1093/eurheartj/ehad600</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37769345</guid>
<pubDate>Thu, 28 Sep 2023 06:00:00 -0400</pubDate>
<dc:creator>Sylvain Diop</dc:creator>
<dc:creator>Virgile Chevance</dc:creator>
<dc:creator>Maïra Gaillard</dc:creator>
<dc:date>2023-09-28</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Cardiac tamponade related oesophageal perforation</dc:title>
<dc:identifier>pmid:37769345</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehad600</dc:identifier>
</item>
<item>
<title>Adverse effects of anthracyclines: does atorvastatin STOP-CArdiotoxicity?</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37769344/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230930040904&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2023 Sep 28:ehad611. doi: 10.1093/eurheartj/ehad611. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37769344/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230930040904&v=2.17.9.post6+86293ac">37769344</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehad611>10.1093/eurheartj/ehad611</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37769344</guid>
<pubDate>Thu, 28 Sep 2023 06:00:00 -0400</pubDate>
<dc:creator>Daniela Pedicino</dc:creator>
<dc:creator>Carlo Patrono</dc:creator>
<dc:date>2023-09-28</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Adverse effects of anthracyclines: does atorvastatin STOP-CArdiotoxicity?</dc:title>
<dc:identifier>pmid:37769344</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehad611</dc:identifier>
</item>
<item>
<title>Meet the First Authors</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37769046/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230930040904&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Circ Res. 2023 Sep 29;133(8):656-657. doi: 10.1161/RES.0000000000000635. Epub 2023 Sep 28.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37769046/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230930040904&v=2.17.9.post6+86293ac">37769046</a> | DOI:<a href=https://doi.org/10.1161/RES.0000000000000635>10.1161/RES.0000000000000635</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37769046</guid>
<pubDate>Thu, 28 Sep 2023 06:00:00 -0400</pubDate>
<dc:date>2023-09-28</dc:date>
<dc:source>Circulation research</dc:source>
<dc:title>Meet the First Authors</dc:title>
<dc:identifier>pmid:37769046</dc:identifier>
<dc:identifier>doi:10.1161/RES.0000000000000635</dc:identifier>
</item>
<item>
<title>Food Is Medicine: A Presidential Advisory From the American Heart Association</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37767686/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230930040904&amp;v=2.17.9.post6+86293ac
      <description>Unhealthy diets are a major impediment to achieving a healthier population in the United States. Although there is a relatively clear sense of what constitutes a healthy diet, most of the US population does not eat healthy food at rates consistent with the recommended clinical guidelines. An abundance of barriers, including food and nutrition insecurity, how food is marketed and advertised, access to and affordability of healthy foods, and behavioral challenges such as a focus on immediate...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2023 Sep 28. doi: 10.1161/CIR.0000000000001182. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Unhealthy diets are a major impediment to achieving a healthier population in the United States. Although there is a relatively clear sense of what constitutes a healthy diet, most of the US population does not eat healthy food at rates consistent with the recommended clinical guidelines. An abundance of barriers, including food and nutrition insecurity, how food is marketed and advertised, access to and affordability of healthy foods, and behavioral challenges such as a focus on immediate versus delayed gratification, stand in the way of healthier dietary patterns for many Americans. Food Is Medicine may be defined as the provision of healthy food resources to prevent, manage, or treat specific clinical conditions in coordination with the health care sector. Although the field has promise, relatively few studies have been conducted with designs that provide strong evidence of associations between Food Is Medicine interventions and health outcomes or health costs. Much work needs to be done to create a stronger body of evidence that convincingly demonstrates the effectiveness and cost-effectiveness of different types of Food Is Medicine interventions. An estimated 90% of the $4.3 trillion annual cost of health care in the United States is spent on medical care for chronic disease. For many of these diseases, diet is a major risk factor, so even modest improvements in diet could have a significant impact. This presidential advisory offers an overview of the state of the field of Food Is Medicine and a road map for a new research initiative that strategically approaches the outstanding questions in the field while prioritizing a human-centered design approach to achieve high rates of patient engagement and sustained behavior change. This will ideally happen in the context of broader efforts to use a health equity-centered approach to enhance the ways in which our food system and related policies support improvements in health.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37767686/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230930040904&v=2.17.9.post6+86293ac">37767686</a> | DOI:<a href=https://doi.org/10.1161/CIR.0000000000001182>10.1161/CIR.0000000000001182</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37767686</guid>
<pubDate>Thu, 28 Sep 2023 06:00:00 -0400</pubDate>
<dc:creator>Kevin G Volpp</dc:creator>
<dc:creator>Seth A Berkowitz</dc:creator>
<dc:creator>Shreela V Sharma</dc:creator>
<dc:creator>Cheryl A M Anderson</dc:creator>
<dc:creator>LaPrincess C Brewer</dc:creator>
<dc:creator>Mitchell S V Elkind</dc:creator>
<dc:creator>Christopher D Gardner</dc:creator>
<dc:creator>Julie E Gervis</dc:creator>
<dc:creator>Robert A Harrington</dc:creator>
<dc:creator>Mario Herrero</dc:creator>
<dc:creator>Alice H Lichtenstein</dc:creator>
<dc:creator>Mark McClellan</dc:creator>
<dc:creator>Jen Muse</dc:creator>
<dc:creator>Christina A Roberto</dc:creator>
<dc:creator>Justin P V Zachariah</dc:creator>
<dc:creator>American Heart Association</dc:creator>
<dc:date>2023-09-28</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Food Is Medicine: A Presidential Advisory From the American Heart Association</dc:title>
<dc:identifier>pmid:37767686</dc:identifier>
<dc:identifier>doi:10.1161/CIR.0000000000001182</dc:identifier>
</item>
<item>
<title>Reply: Cardiac Remodeling in Aortic Regurgitation</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37758444/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230930040904&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">J Am Coll Cardiol. 2023 Oct 3;82(14):e125. doi: 10.1016/j.jacc.2023.07.022.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37758444/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230930040904&v=2.17.9.post6+86293ac">37758444</a> | DOI:<a href=https://doi.org/10.1016/j.jacc.2023.07.022>10.1016/j.jacc.2023.07.022</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37758444</guid>
<pubDate>Wed, 27 Sep 2023 06:00:00 -0400</pubDate>
<dc:creator>Maan Malahfji</dc:creator>
<dc:creator>Duc T Nguyen</dc:creator>
<dc:creator>Edward A Graviss</dc:creator>
<dc:creator>Dipan J Shah</dc:creator>
<dc:date>2023-09-27</dc:date>
<dc:source>Journal of the American College of Cardiology</dc:source>
<dc:title>Reply: Cardiac Remodeling in Aortic Regurgitation</dc:title>
<dc:identifier>pmid:37758444</dc:identifier>
<dc:identifier>doi:10.1016/j.jacc.2023.07.022</dc:identifier>
</item>
<item>
<title>Left Ventricular Remodeling in Aortic Regurgitation</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37758443/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230930040904&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">J Am Coll Cardiol. 2023 Oct 3;82(14):e123. doi: 10.1016/j.jacc.2023.06.049.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37758443/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230930040904&v=2.17.9.post6+86293ac">37758443</a> | DOI:<a href=https://doi.org/10.1016/j.jacc.2023.06.049>10.1016/j.jacc.2023.06.049</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37758443</guid>
<pubDate>Wed, 27 Sep 2023 06:00:00 -0400</pubDate>
<dc:creator>Ramdas G Pai</dc:creator>
<dc:date>2023-09-27</dc:date>
<dc:source>Journal of the American College of Cardiology</dc:source>
<dc:title>Left Ventricular Remodeling in Aortic Regurgitation</dc:title>
<dc:identifier>pmid:37758443</dc:identifier>
<dc:identifier>doi:10.1016/j.jacc.2023.06.049</dc:identifier>
</item>





























</channel>
</rss>